IN2014MU00859A - - Google Patents

Info

Publication number
IN2014MU00859A
IN2014MU00859A IN859MU2014A IN2014MU00859A IN 2014MU00859 A IN2014MU00859 A IN 2014MU00859A IN 859MU2014 A IN859MU2014 A IN 859MU2014A IN 2014MU00859 A IN2014MU00859 A IN 2014MU00859A
Authority
IN
India
Prior art keywords
acceptable derivative
pharmaceutical
sulbactam
stereoisomer
compound
Prior art date
Application number
Other languages
English (en)
Inventor
Sachin Bhagwat
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to JP2016555984A priority Critical patent/JP2017507162A/ja
Priority to IN859MU2014 priority patent/IN2014MU00859A/en
Priority to EP15706530.1A priority patent/EP3116545A1/fr
Priority to US15/125,562 priority patent/US20170000775A1/en
Priority to CN201580014021.1A priority patent/CN106794250A/zh
Priority to KR1020167025810A priority patent/KR20160126004A/ko
Priority to PCT/IB2015/050267 priority patent/WO2015136387A1/fr
Publication of IN2014MU00859A publication Critical patent/IN2014MU00859A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN859MU2014 2014-03-14 2015-01-14 IN2014MU00859A (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP2016555984A JP2017507162A (ja) 2014-03-14 2015-01-14 抗菌薬を含む医薬組成物
IN859MU2014 IN2014MU00859A (fr) 2014-03-14 2015-01-14
EP15706530.1A EP3116545A1 (fr) 2014-03-14 2015-01-14 Compositions pharmaceutiques comprenant des agents antibactériens
US15/125,562 US20170000775A1 (en) 2014-03-14 2015-01-14 Pharmaceutical compositions comprising antibacterial agents
CN201580014021.1A CN106794250A (zh) 2014-03-14 2015-01-14 包含抗菌剂的药物组合物
KR1020167025810A KR20160126004A (ko) 2014-03-14 2015-01-14 항세균제를 포함하는 제약학적 조성물
PCT/IB2015/050267 WO2015136387A1 (fr) 2014-03-14 2015-01-14 Compositions pharmaceutiques comprenant des agents antibactériens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN859MU2014 IN2014MU00859A (fr) 2014-03-14 2015-01-14

Publications (1)

Publication Number Publication Date
IN2014MU00859A true IN2014MU00859A (fr) 2015-10-02

Family

ID=52589710

Family Applications (1)

Application Number Title Priority Date Filing Date
IN859MU2014 IN2014MU00859A (fr) 2014-03-14 2015-01-14

Country Status (7)

Country Link
US (1) US20170000775A1 (fr)
EP (1) EP3116545A1 (fr)
JP (1) JP2017507162A (fr)
KR (1) KR20160126004A (fr)
CN (1) CN106794250A (fr)
IN (1) IN2014MU00859A (fr)
WO (1) WO2015136387A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016151543A1 (fr) * 2015-03-25 2016-09-29 Wockhardt Limited Compositions pharmaceutiques comprenant des agents antibactériens
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011373911B2 (en) * 2011-07-26 2016-09-22 Wockhardt Limited Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
EP2768503A1 (fr) * 2011-07-26 2014-08-27 Wockhardt Limited Compositions pharmaceutiques comprenant un antibiotique bêta-lactame, du sulbactam et un inhibiteur de bêta-lactamase
CN103781787B (zh) * 2011-09-13 2015-09-23 沃克哈特有限公司 含氮化合物及其用途

Also Published As

Publication number Publication date
KR20160126004A (ko) 2016-11-01
JP2017507162A (ja) 2017-03-16
CN106794250A (zh) 2017-05-31
WO2015136387A1 (fr) 2015-09-17
EP3116545A1 (fr) 2017-01-18
US20170000775A1 (en) 2017-01-05

Similar Documents

Publication Publication Date Title
PH12018500591A1 (en) Heterocyclic compounds and uses thereof
TW201613911A (en) Heterocyclic compounds and uses thereof
GEP20207075B (en) New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them
MA39749A (fr) Dérivés de pipéridine-dione
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MY181641A (en) Amino pyran ring derivative and composition and use thereof
PH12016501252A1 (en) Novel tetrahydropyridopyrimidine compound or salt thereof
MX2017016619A (es) Derivados de pirimidina como inhibidores de tirosina cinasa de bruton (btk) y usos de los mismos.
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
EP3213746A4 (fr) Composition pharmaceutique pour administration orale comprenant un taxane
IN2014CH00840A (fr)
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
EP3720844A4 (fr) Compositions de médicaments
TW201613898A (en) Benzofuran analogue as NS4B inhibitor
IN2014MU00859A (fr)
MA39877A (fr) Formes solides d'un composé pharmaceutiquement actif
IN2013MU03704A (fr)
IN2013MU03422A (fr)
IN2013MU03421A (fr)
IN2013MU03308A (fr)
IN2013MU03309A (fr)
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
IN2014MU01194A (fr)